Rectal cancer drug trial of dostarlimab cures all patients: report
June 10, 2022 at 13:14 PM EDT
A clinical trial of dostarlimab, done by Memorial Sloan Kettering Cancer Center, found the drug appears to have completely cured 12 patients of rectal cancer.
